Lacadman, Mark Jeo A.

HRN: 23-52-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/19/2024
08/26/2024
PO
1ml
QID
Mouth Sores
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Eye, Ear, Nose, Throat, & MouthProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: